Podcast

Introduction to Benefit-Risk Assessment

By Alexander on 2019-03-19 0

Interview with Maria Costa and Shahrul Mt-Isa

Benefit-risk assessments are made by various stakeholders including sponsors, regulators, payers, physicians, and patients throughout the life-cycle of a treatment.

The understanding of data plays a vital role in weighting positive and negative effects of medications.

In this episode, we give you an introduction to what benefit-risk (BR) assessment is in order for you to understand your role.

We also cover the following topics:

[Read more…]

How to get most out of a conference

By Alexander on 2019-03-12 0

Interview with Kate Taylor – chair of the PSI conference in 2019

Hopefully, you’re attending statistical conferences to learn more about the latest developments in the field. But of course, there’s much more to conferences than just the sessions.

In this episode, I’m chatting with Kate Taylor – the chair of the PSI conference 2019 in London- about how to get most out of a conference. Of course, we take the upcoming PSI conference as an example.

In this episode, we talk about

[Read more…]

Introduction to cluster analysis

By Alexander on 2019-03-05 0

Not all patients are created equal, but are there subgroups that are more homogenous?

This episode follows the outline of a webinar, that I presented in 2018 during a PSI webinar. I’m introducing cluster analysis and why you as a statistician need to know about it.

The title of the presentation was “Not all patients are created equal, but are there subgroups that are more homogenous?”

If you wonder about questions like:

[Read more…]

Data science or just statistics on non-medical data? A new horizon for statisticians

By Alexander on 2019-02-26 0

Interview with Stephen Ruberg

There’s a long tradition of statisticians working on clinical studies as well as other related data, e.g. pre-clinical data and observational data. In the advent of big data and data sciences, there’s a considerable pull from the business side of pharma to employ statistical approaches as well.

This leads to questions like:

[Read more…]

Current trends in data science for pharma – findings from a qualitative survey and what we should do about it!

By Alexander on 2019-02-19 0

Interview with Ursula Garczarek

Do you want to learn where the health sector might be heading in terms of data science?

Do you understand the opportunities and barriers in terms of the application of data science?

Are you prepared to learn the individual skills needed for these changes?

Then this interview with Ursula from Cytel provides you with the relevant answers. We are talking about:

[Read more…]

What you can learn about communication of statistics from a statistician working for the BBC

By Alexander on 2019-02-12 0

It’s surely not the norm, that a statistician from the pharma sector ends up working for BBC. But Robert Cuffe has taken this step and needs to explain statistics to non-statisticians on a daily basis.

In this episode, he shares the different methods he’s using. We also dive into common pitfalls, that we as statisticians trap into.

Finally, we also learn, how we can improve our publications to make sure, that the science is reported correctly in the broader news

[Read more…]